Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present quality ...
Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...
TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...
The basement of the Northeastern University Catholic Center in Boston on the night of Jan. 23 looked like any other college ...
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that ...
Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 5 years ago, it would be worth $2,432.39 today based on a ...
The BPD says Toussaint Gonsalves was born on Oct. 2, 1970. When he was stabbed to death in late 1991, at age 21, he was ...
The history of the Skating Club of Boston is the history of American figure skating. In good times and in bad.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...
Zacks.com on MSN4d
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?Boston Scientific (BSX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback